Elevance Health, Inc.

Robeco Institutional Asset Management B.V. ELV

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/23/2026

Shares

30,898

Value ($000)

10,831

Weight

0.0%

2017 Q1 - 2025 Q4 (36 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/23/2026	10,831	0.0%	30,898	12/31/2025
2025 Q3	10/22/2025	18,825	0.0%	58,260	9/30/2025
2025 Q2	7/18/2025	34,973	0.1%	89,913	6/30/2025
2025 Q1	4/23/2025	51,462	0.1%	118,315	3/31/2025
2024 Q4	1/23/2025	48,372	0.1%	131,125	12/31/2024
2024 Q3	10/29/2024	108,181	0.2%	208,041	9/30/2024
2024 Q2	7/23/2024	127,246	0.3%	234,831	6/30/2024
2024 Q1	4/24/2024	124,464	0.3%	240,028	3/31/2024
2023 Q4	2/14/2024	121,582	0.3%	257,830	12/31/2023
2023 Q3	10/24/2023	102,038	0.3%	234,343	9/30/2023
2023 Q2	7/24/2023	114,850	0.3%	258,502	6/30/2023
2023 Q1	5/4/2023	135,583	0.4%	294,867	3/31/2023
2022 Q4	2/7/2023	257,718	0.7%	502,403	12/31/2022
2022 Q3	12/1/2022	321,183	1.0%	707,075	9/30/2022
2022 Q2	12/1/2022	351,501	1.1%	728,375	6/30/2022
2022 Q1	12/1/2022	345,660	0.8%	703,677	3/31/2022
2021 Q4	12/1/2022	309,655	0.7%	668,024	12/31/2021
2021 Q3	12/1/2022	222,688	0.5%	597,343	9/30/2021
2021 Q2	12/1/2022	225,945	0.5%	591,784	6/30/2021
2021 Q1	12/1/2022	163,041	0.4%	454,210	3/31/2021
2020 Q4	12/1/2022	144,396	0.4%	449,699	12/31/2020
2020 Q3	1/19/2021	133,012	0.4%	495,216	9/30/2020
2020 Q2	1/19/2021	126,971	0.4%	482,829	6/30/2020
2020 Q1	1/19/2021	110,598	0.4%	487,110	3/31/2020
2019 Q4	1/19/2021	143,490	0.5%	475,095	12/31/2019
2019 Q3	1/19/2021	128,682	0.5%	535,964	9/30/2019
2019 Q2	1/19/2021	156,893	0.6%	555,961	6/30/2019
2019 Q1	1/19/2021	158,829	0.6%	553,440	3/31/2019
2018 Q4	1/19/2021	138,645	0.6%	528,318	12/31/2018
2018 Q3	1/19/2021	182,205	0.7%	664,869	9/30/2018
2018 Q2	1/19/2021	170,084	0.8%	714,551	6/30/2018
2018 Q1	1/19/2021	159,865	0.8%	727,660	3/31/2018
2017 Q4	1/19/2021	159,762	0.8%	710,014	12/31/2017
2017 Q3	1/19/2021	92,258	0.6%	485,888	9/30/2017
2017 Q2	1/19/2021	83,046	0.5%	441,434	6/30/2017
2017 Q1	1/19/2021	40,811	0.3%	246,764	3/31/2017